Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Samorita HospitalDHA:SAMORITA +0.94%18 EV-to-EBIT is 0.00 as of Sep. 22, 2026. GuruFocus rates DHA:SAMORITA with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 481 Healthcare Providers & Services companies, Samorita Hospital ranks worse than 207900% on this metric.
The historical rank and industry rank for Samorita Hospital's EV-to-EBIT or its related term are showing as below:
DHA:SAMORITA's EV-to-EBIT is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 15.08 * Ranked among companies with meaningful EV-to-EBIT only.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Samorita Hospital's Enterprise Value for the quarter that ended in Mar. 2026 was BDT1,468.5 Mil.
Samorita Hospital's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT23.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Samorita Hospital EV-to-EBIT Related Terms
Samorita Hospital EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Samorita Hospital's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:SAMORITA vs SPIN, USNU, CHCR: EV-to-EBIT Comparison
For the Medical Care Facilities subindustry, Samorita Hospital's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Samorita Hospital EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Samorita Hospital's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Samorita Hospital's EV-to-EBIT falls into.
Samorita Hospital's current Enterprise Value is BDT0.0 Mil.
Samorita Hospital's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT23.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Samorita Hospital (DHA:SAMORITA) has a EV-to-EBIT of 0.00 as of Sep. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Samorita Hospital and its competitors. According to the industry distribution chart, Samorita Hospital ranks #999999 out of 481 companies in the Healthcare Providers & Services industry.
Is Samorita Hospital's EV-to-EBIT too high?
Samorita Hospital's current EV-to-EBIT is 0.00. Based on the distribution chart, Samorita Hospital ranks #999999 out of 481 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Samorita Hospital has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Samorita Hospital's EV-to-EBIT compare to SPIN and USNU?
According to the Healthcare Providers & Services industry distribution chart, Samorita Hospital ranks #999999 out of 481 companies for EV-to-EBIT. This places Samorita Hospital in the lower half of its industry. The industry median EV-to-EBIT is 15.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.08, based on 481 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Samorita Hospital and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Samorita Hospital's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samorita Hospital stock overvalued right now?
Samorita Hospital (DHA:SAMORITA) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. Samorita Hospital's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Samorita Hospital (DHA:SAMORITA), the current EV-to-EBIT is 0.00 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Samorita Hospital Ltd provides general hospital services including all types of medical treatment along with diagnostic services in Bangladesh. It offers various clinical services in the areas of internal medicine, neurology, diabetes and endocrinology, nephrology, respiratory medicine, gastroenterology and other.
18GF Score
Get the complete analysis for DHA:SAMORITA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:SAMORITA has been successfully added to your 
